Source: International Congress 2014 – Environment and mechanisms
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Orlova, E. Surkova (Saint-Petersburg, Russian Federation). Clara cell protein 16 (CC16) and markers of fibrosis in exogenous toxic (ETA) and exogenous allergic (EAA) alveolites. Eur Respir J 2014; 44: Suppl. 58, 1099

Member's Comments

No comment yet.

Related content which might interest you: A mechanism for acceleration of GM-CSF autoantibody (GMAb) production in autoimmune pulmonary alveolar proteinosis (aPAP) Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 Chemical and hard metal induced exogenous toxic alveolitis (ETA) (follow up 1,5 years) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Alveolomucin and KL6 as markers of exogenous alveolitis progression Source: International Congress 2014 – Environment and mechanisms Year: 2014 Pulmonary alveolar proteinosis (PAP) in exogenous toxic alveolitis (ETA) patients Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Use of acetylcysteinein the treatment of patients with exogenic allergic alveolitis (EAA) Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Safety of sputum induction (SI) in interstitial lung disease (ILD) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007 House dust mites (HDM) natural exposure and alpha1 –acid glycoprotein (alpha1-AGP) level in expired air condensates (EAC) and nasal lavage fluid (NLF) of children with bronchial asthma (BA) and allergic rhinitis (AR) Source: International Congress 2014 – Environment and mechanisms Year: 2014 Enhanced expression of interleukin 8 (CXCL8) in cystic fibrosis (CF) airway epithelial (AE) cells Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Pirfenidone suppresses proinflammatory and antiangiogenetic cytokine production by alveolar macrophages (AMs) in idiopathic non specific interstitial pneumonia (iNSIP) Source: International Congress 2014 – ILDs 2 Year: 2014 Radiological and morphological patterns in pneumoconiosis (PC) and exogenous toxic alveolitis (ETA) Source: Eur Respir J 2001; 18: Suppl. 33, 528s Year: 2001 mRNA expression of YY1, TNF-α a TGF-β in lung samples gained by transbronchial biopsies (TBB) in patients with different interstitial lung diseases (ILDs) Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Studies on apoptosis of alveolar lymphocytes (AL) in exogenous allergic alveolitis (EAA) Source: International Congress 2016 – ILD pathogenesis Year: 2016 Detection of anti DFS70 antibodies in patients with interstitial lung disease (ILD) with and without connective tissue disease (CTD) Source: International Congress 2016 – Connective tissue disorders Year: 2016 Difference in immunological aspects of inflammation in idiopathic pulmonary fibrosis (IPF) and exogenous toxic alveolitis (ETA) Source: Eur Respir J 2003; 22: Suppl. 45, 121s Year: 2003 Prevalence of occupational and environmental exposures in Australian patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2014 – Occupational asthma, abestosis and silicosis Year: 2014 Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Enhanced interleukin-18 expression in rodent models of quartz induced fibrosis Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 Clara cell secretory protein (CC16) and surfactant protein D (SPD) in sputum supernatant in severe refractory asthma (SRA) Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Levels of cytokines, sCD31 and expression of CD38 in patients with bronchial asthma of various severity out of a disease exacerbation Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD) Source: International Congress 2015 – IPF: from bench to bedside Year: 2015